Functional interrogation of the kinome using nucleotide acyl phosphates.

The central role of protein kinases in signal transduction pathways has generated intense interest in targeting these enzymes for a wide range of therapeutic indications. Here we report a method for identifying and quantifying protein kinases in any biological sample or tissue from any species. The procedure relies on acyl phosphate-containing nucleotides, prepared from a biotin derivative and ATP or ADP. The acyl phosphate probes react selectively and covalently at the ATP binding sites of at least 75% of the known human protein kinases. Biotinylated peptide fragments from labeled proteomes are captured and then sequenced and identified using a mass spectrometry-based analysis platform to determine the kinases present and their relative levels. Further, direct competition between the probes and inhibitors can be assessed to determine inhibitor potency and selectivity against native protein kinases, as well as hundreds of other ATPases. The ability to broadly profile kinase activities in native proteomes offers an exciting prospect for both target discovery and inhibitor selectivity profiling.

[1]  Zhengui Huang,et al.  Acyl pyrophosphates: activated analogs of pyrophosphate monoesters permitting new designs for inactivation of targeted enzymes , 1991 .

[2]  G. Novelli,et al.  THE ENZYMATIC ACTIVATION OF AMINO ACIDS VIA THEIR ACYL-ADENYLATE DERIVATIVES. , 1956, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Burbaum,et al.  Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site‐directed probes , 2001, Proteomics.

[4]  B. Cravatt,et al.  Mapping enzyme active sites in complex proteomes. , 2004, Journal of the American Chemical Society.

[5]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Sewald,et al.  Chemical tools for activity-based proteomics. , 2006, Journal of biotechnology.

[7]  A. Burlingame,et al.  Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.

[8]  M. Bogyo,et al.  Activity-Based Protein Profiling , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[9]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[10]  M. Vieth,et al.  Kinomics: characterizing the therapeutically validated kinase space. , 2005, Drug discovery today.

[11]  Nguyen-Huu Xuong,et al.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with magnesium-ATP and peptide inhibitor , 1993 .

[12]  Nasreen S Jessani,et al.  The development and application of methods for activity-based protein profiling. , 2004, Current opinion in chemical biology.

[13]  Baohong Zhang,et al.  High-resolution functional proteomics by active-site peptide profiling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Alison Martin,et al.  U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid. , 2002, The oncologist.

[15]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. , 1993, Biochemistry.

[16]  A. Kreimeyer,et al.  SYNTHESIS OF ACYLPHOSPHATES OF PURINE RIBONUCLEOSIDES , 1996 .

[17]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[18]  K. Penne,et al.  Gefitinib (IressaTM, ZD1839) and Tyrosine Kinase Inhibitors: The Wave of the Future in Cancer Therapy , 2005, Cancer nursing.

[19]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[20]  R. Kluger,et al.  Cross-linked bis-hemoglobins: connections and oxygen binding. , 2003, Journal of the American Chemical Society.

[21]  S. Kim,et al.  High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design. , 1996, Journal of medicinal chemistry.

[22]  D. Ja,et al.  THE ENZYMATIC ACTIVATION OF AMINO ACIDS VIA THEIR ACYL-ADENYLATE DERIVATIVES. , 1956 .

[23]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[25]  Min Wu,et al.  Fishing for targets: novel approaches using small molecule baits. , 2004, Drug discovery today. Technologies.

[26]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[27]  W. Jencks,et al.  Mechanism and Catalysis of Reactions of Acyl Phosphates. I. Nucleophilic Reactions1 , 1961 .

[28]  Z. Shabarova,et al.  Design and synthesis of double‐stranded oligonucleotides containing reactive acylphosphate internucleotide groups , 1998, FEBS letters.